World UFO Day, disco, and…Operation *Trial* blazer?
In this episode of **Note to File**, Brad and Denali kick things off with some classic nonsense—World UFO Day, Roswell, National Disco Day, and why U.S. soccer fandom magically appears every four years—before diving into a serious (and pretty spicy) breakdown of **clinical trial access, economics, and Operation Trailblazer**.
We unpack:
- Why only **3–7% of oncology patients** ever make it into a trial—even though the majority say they *would* participate
- How **economic and household realities** (time off work, travel, childcare, insurance coverage) quietly gatekeep trial participation
- Why **oncology, IBD, chronic pain, and derm** behave very differently when it comes to trial incentives
- The tension between **protocol design vs. real-world feasibility** and whether we're making research harder than it needs to be
- What **Operation Trailblazer / "Trial Blazer"** actually is, who it's really built around (QRIs, AMCs, big systems), and what that means for **community sites and site networks**
- Whether government is fixing **paperwork problems or patient problems**
- EHR flags, master protocols, single pivotal trials, anti‑kickback safe harbors, and why **adoption** of existing guidance may matter more than any new initiative
- The weird mix of **American exceptionalism, global competition, and budget cuts** that shape U.S. research policy
If you care about **site-level reality**, **patient access**, and how policy actually hits the ground (or doesn't), this one's for you.
**Timestamps (approx):**
0:00 Cold open & intro
3:20 World UFO Day, aliens, and deep-sea vs deep-space
7:40 Made in the USA Day, World Cup, and U.S. soccer culture
10:15 National Disco Day & Note to File playlist ideas
11:55 Why so few oncology patients join clinical trials
16:30 Insurance, community cancer centers, and structural barriers
19:40 Are we making trials hard on purpose—or just badly?
20:50 Operation Trailblazer / "Trial Blazer" overview
23:10 Qualified Research Institutions (QRIs) & phase I focus
24:45 Could community sites do this better than AMCs?
27:00 EHR flags and why doctors mostly click past them
29:45 Participant payments, undue influence, and safe harbor
31:30 Single pivotal trials & what that means for sites
33:30 Master protocols & not reinventing the wheel
36:00 Policy, trust, and guidance no one follows
39:00 Fourth of July disco playlist & outro
**Listen if you're into:**
- Clinical trial operations & site strategy
- Oncology and access to innovation
- U.S. research policy & Operation Trailblazer
- Real talk about what actually works at the site level
